Abstract
We used the SOD1G93A transgenic mice as an in vivo model of amyotrophic lateral sclerosis (ALS) and performed immunohistochemical studies to investigate whether α-synuclein is involved in the pathogenesis of ALS. In the spinal cord of transgenic mice, immunohistochemistry showed intense staining of α-synuclein mainly in the anterior horn. In the hippocampus of transgenic mice, differential increases in the staining density of α-synuclein were observed. In the cerebellar cortex of transgenic mice, the prominent immunostaining of α-synuclein was found in the molecular and granular layers. The present study provides the first in vivo evidence that α-synuclein immunoreactivity was increased in the central nervous system of SODG93A transgenic mice, suggesting that α-synuclein might play an important role in the pathogenesis of ALS. However, the functional implications of these increases require elucidation.
| Original language | English |
|---|---|
| Pages (from-to) | 151-154 |
| Number of pages | 4 |
| Journal | Neuroscience Letters |
| Volume | 342 |
| Issue number | 3 |
| DOIs | |
| State | Published - 22 May 2003 |
| Externally published | Yes |
Keywords
- Amyotrophic lateral sclerosis
- Hippocampus
- Immunohistochemistry
- Spinal cord
- Transgenic mice
- α-Synuclein